Technical Feasibility:
• Goal 1 - Definition of the final features of the NMR device:
During the phase 1 project, the proposed technology has been validated by means of interactions with key stakeholders. As a result, the final attributes and specifications for the main blocks that compose the Embryospin solution have been defined;
• Goal 2 - Description of the laboratory tests performed on the Measuring Unit, prototypes, casing and probe insert. Definition of a set of markers to ensure the highest accuracy and effectiveness during the analysis:
Several tests have been conducted to evaluate the performance of the Embryospin solution, with particular reference to embryo’s metabolism.
• Goal 3 - Definition of the measuring protocol:
During the phase 1 project, there were several interactions with embryologists from IVF clinics, which represent Annaida’s potential key customers, in order to define a measuring protocol, which is in line with their best practices related to embryo manipulation.
• Goal 4 - Certification of materials biocompatibility:
Tests to certify the safety of materials have been successfully conducted using standard Mouse Embryo Assays
Business Feasibility:
• Goal 1 - Validation of the expected benefits, of the pricing, and the distribution network:
The Embryospin’s business model have been validated by means of interactions with key stakeholders. As a result, the Embryospin’s value proposition and Annaida’s value chain have been defined.
• Goal 2 - Market Analysis: estimation of the potential demand and understanding of the entry barriers:
A market analysis has been performed, estimating the Embryospin addressable and obtainable market. By means of interactions with prospected customers, the main entry barriers have been identified, finding the associated counteractions.
• Goal 3 - Financial projections:
Multi-annual economic and financial projections have been outlined, in order to derive economic indicators that can support the investment decision.
